Sheppard Mullin advised Decoy Biosystems , Inc. on the deal.Decoy Biosystems, Inc., a privately held, preclinical-stage biotechnology company developing novel, multi-targeted products that safely prime both…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
